Today there are more highly effective treatments for patients with HIV. However, these patients can also have higher rates of hepatitis C infection. Even though the HIV is…
NEW YORK (Reuters Health) – A second dose of quadrivalent meningococcal conjugate vaccine (MCV4) 6 months after the first dose significantly improves response rates in youth infected with…
Treatment, education and prevention have been the focus of the United States when it comes to addressing the HIV/AIDS epidemic in Africa. In 2003, the President’s Emergency Plan…
NEW YORK (Reuters Health) – Individuals infected with HIV face an increased risk of sudden cardiac death (SCD), according to findings published in the May 22nd Journal of…
NEW YORK (Reuters Health) – Patients with HIV infection who are admitted to the hospital with acute coronary syndrome (ACS) face a “substantial” risk of dying in the…
NEW YORK (Reuters Health) – A pooled analysis of two trials indicates that HIV patients with aggressive B-cell non-Hodgkin lymphoma (NHL) fare better with a regimen of rituximab…
NEW YORK (Reuters Health) – In pregnant HIV-infected women treated with a single intrapartum dose of nevirapine (NVP) to prevent vertical HIV transmission, the subsequent selection of nevirapine-resistant…
NEW YORK (Reuters Health) – Moxifloxacin is as effective as amoxicillin/clavulanic acid in the treatment of exacerbations of chronic obstructive pulmonary disease (COPD) in the outpatient setting, according…
NEW YORK (Reuters Health) – For the initial treatment of HIV-associated cryptococcal meningitis, amphotericin B plus fluconazole is a good alternative to amphotericin B plus flucytosine (5-FC), the…
NEW YORK (Reuters Health) – The lipoarabinomannan (LAM) urinary assay isn’t accurate enough to be used for routine TB diagnosis, according to a new review in the European…
